2021年4月22日、アモイ知的財産権法廷は、エマソン・エレクトリック社(以下、「エマソン」といいます)がA社等を訴えた不正競争紛争事件の第一審判決を下し、被告1のA社、被告2のH社、及び2社の事実上の管理者である被告3のWに対し、10年近くエマソンに対し行った大量の冒認出願(商標の抜け駆け登録)行為を停止するよう命じ、冒認出願対応に要した弁護士費用の損失を賠償するとともに、影響を排除するための声明を発表するよう命じました。また、被告3者の商標代理機構に対しても、侵害幇助に該当するとし、エマソンに対し損害を賠償するよう命じました。
Continue Reading 中国裁判所、初の冒認出願差止命令、冒認出願の弁護士費用支払を原告に命じる
金杜律师事务所在大湾区打造金杜国际中心
作者:金杜律师事务所
金杜律师事务所中国管委会主席张毅于2018年4月28日宣布,成立由张毅总体牵头,与事务所管理合伙人及香港、深圳和广州办公室负责合伙人共同组成金杜国际中心推动工作小组,在大湾区打造金杜国际中心。金杜中国管理合伙人王玲将赴深圳共同推动国际中心的建设工作。
Continue Reading 金杜律师事务所在大湾区打造金杜国际中心
King & Wood Mallesons advises Yunfeng Fund and MicroPort jointly acquired LivaNova PLC’s cardiac rhythm management business ranking fifth largest in the world
By King & Wood Mallesons
On February 20, 2018, Yunfeng Fund signed the agreement with MicroPort Scientific Corporation (“MicroPort”, HK:853), a medical company listed in Hong Kong, jointly acquiring cardiac rhythm management business (CRM business) of LivaNova PLC in the United Kingdom by funding MicroPort Cardiac Rhythm B.V. (“MicroPort Cardiac”). The business mainly includes R&D, manufacture and sale of pacemakers, defibrillators and cardiac resynchronization devices with the purchase price of 190 million U.S. dollars. Upon completion of the acquisition, Yunfeng Fund will indirectly hold 25% of the CRM business through MicroPort Cardiac.
Continue Reading King & Wood Mallesons advises Yunfeng Fund and MicroPort jointly acquired LivaNova PLC’s cardiac rhythm management business ranking fifth largest in the world
King & Wood Mallesons Partner Gao Feng named among 2018 ALB China TOP 15 Litigators
By King & Wood Mallesons
On 22 February 2018, King & Wood Mallesons (KWM) partner Mr. Gao Feng has been named to 2018 China TOP 15 Litigators by Asian Legal Business (ALB) for his excellent performance and wide recognition by clients. ALB China research team annually selects the top 15 litigators in China who are representative and influential in the industry based on their high-profile cases, clients’ recommendations and feedback from the market.
Continue Reading King & Wood Mallesons Partner Gao Feng named among 2018 ALB China TOP 15 Litigators
KWM advises on By-Health’s $690m investment in Australia’s healthcare industry
By King & Wood Mallesons
King & Wood Mallesons (KWM) has advised Shenzhen-listed By-Health Co., Ltd. on the acquisition of Australian probiotic market leader Life-Space Group, for a purchase price of up to A$690 million.
Continue Reading KWM advises on By-Health’s $690m investment in Australia’s healthcare industry
KWM advises on By-Health’s AU$690m investment in Australia’s healthcare industry
By King & Wood Mallesons
King & Wood Mallesons (KWM) has advised Shenzhen-listed By-Health Co., Ltd. on the acquisition of Australian probiotic market leader Life-Space Group, for a purchase price of up to AU$690 million.
The transaction represents By-Health’s first major outbound acquisition in the Australian healthcare industry, with Life-Space operating the Evolution Health and Ultramix businesses as well as the Life-Space brand of probiotics.
Continue Reading KWM advises on By-Health’s AU$690m investment in Australia’s healthcare industry
King & Wood Mallesons won multiple Deals of the Year 2017 from China Business Law Journal
By King & Wood Mallesons
In January 2018, King & Wood Mallesons (KWM) was recognized with eight Deals of the Year 2017 by China Business Law Journal (CBLJ). As one of the most influential deal awards in the region, CBLJ’s annual Deals of the Year awards select top ten most representative deals/cases from significant business deals, litigation disputes and intellectual property (IP) matters in China. The eight selected matters advised by KWM cover corporate and M&A, securities & capital markets, aviation finance and dispute resolution, and other practice areas, representing comprehensive strength of the firm in those sectors.
Continue Reading King & Wood Mallesons won multiple Deals of the Year 2017 from China Business Law Journal
King & Wood Mallesons advises renowned AI startup Horizon Robotics on its over US$100 million Series A+ preferred equity financing
By King & Wood Mallesons
In December 2017, King & Wood Mallesons (“KWM”) advised Beijing Horizon Robotics Technology Research and Development Co., Ltd. (“Horizon Robotics”) on its successful series A+ financing. This preferred equity financing raised approximately US$100 million. Although Horizon Robotics was only established two years ago, it has achieved extraordinary growth in its business valuation and has strengthened its competitive edge in the artificial intelligence (“AI”) industry as a result of this transaction.
Continue Reading King & Wood Mallesons advises renowned AI startup Horizon Robotics on its over US$100 million Series A+ preferred equity financing
King & Wood Mallesons advises Comsys on A380 aircraft acquisition and refinancing
By King & Wood Mallesons
King & Wood Mallesons (KWM) advised Comsys Financial Leasing (Comsys) on its acquisition and finance leasing of an A380 aircraft to Mauritius-based operating lessor, Veling Group (Veling), with a 12 year operating lease attached to Emirates. Comsys financed its acquisition of the aircraft with a secured loan from a PRC policy bank.
Continue Reading King & Wood Mallesons advises Comsys on A380 aircraft acquisition and refinancing
King & Wood Mallesons represents NextView Capital on its acquisition of a 19.89% equity interest in Bacanora Minerals Ltd.
By King & Wood Mallesons
King & Wood Mallesons represented NextView Capital (‘NextView’), a leading Chinese institutional fund management group focused on new technologies and energy in its acquisition of a 19.89% equity interest (non-diluted) in Bacanora Minerals Ltd. (a company listed on the TSX and on AIM) via the placement of 32,976,635 common shares at a price of 94.53 pence per share raising £31,172,813 (approximately C$53,498,000).
Continue Reading King & Wood Mallesons represents NextView Capital on its acquisition of a 19.89% equity interest in Bacanora Minerals Ltd.